Predicting Survival in Patients Receiving Continuous Flow Left Ventricular Assist DevicesJennifer Cowger, Mark S. Slaughter, Kartik S. Sundareswaran et al.|Journal of the American College of Cardiology|2012Cited by 316
Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapyMark S. Slaughter, Francis D. Pagani, Kartik S. Sundareswaran et al.|The Journal of Heart and Lung Transplantation|2010Cited by 141
Extremes of body mass index do not impact mid-term survival after continuous-flow left ventricular assist device implantationRobert J. Brewer, Mark S. Slaughter, David E. Lanfear et al.|The Journal of Heart and Lung Transplantation|2012Cited by 60
The Incidence, Risk, and Consequences of Atrial Arrhythmias in Patients with Continuous-Flow Left Ventricular Assist DevicesMeredith A. Brisco, Lee R. Goldberg, Kartik S. Sundareswaran et al.|Journal of Cardiac Surgery|2014Cited by 51
Patients with low compared with high body mass index gain more weight after implantation of a continuous-flow left ventricular assist deviceSitaramesh Emani, Chittoor Sai‐Sudhakar, Robert J. Brewer et al.|The Journal of Heart and Lung Transplantation|2012Cited by 49